BACKGROUND: Impairments of olfactory and speech function are likely early prodromal symptoms of α-synucleinopathy. OBJECTIVE: The aim of this study is to assess whether dysprosody is present in isolated rapid eye movement sleep behavior disorder (iRBD) with hyposmia/anosmia and a normal nigrostriatal system. METHODS: Pitch variability during speech was investigated in 17 iRBD subjects with normal olfactory function (iRBD-NOF), 30 iRBD subjects with abnormal olfactory function (iRBD-AOF), and 50 healthy controls. iRBD subjects were evaluated using the University of Pennsylvania Smell Identification Test and [123I]-2ß-carbomethoxy-3ß-(4-iodophenyl)-N-(3-fluoropropyl)-nortropane dopamine transporter single-photon emission computed tomography (DAT-SPECT). All iRBD subjects completed the 24-month follow-up with DAT-SPECT, speech, and olfactory testing. RESULTS: At baseline, only iRBD-AOF showed monopitch when compared to iRBD-NOF (P = 0.04) and controls (P = 0.03), with no difference between iRBD-NOF and controls (P = 1). At follow-up, dysprosody progressed only in iRBD-AOF with abnormal DAT-SPECT (P = 0.03). CONCLUSION: Prosody is impaired in hyposmic but not in normosmic iRBD subjects before the nigrostriatal dopaminergic transmission is affected (Braak stage 2). © 2021 International Parkinson and Movement Disorder Society.

Department of Circuit Theory Faculty of Electrical Engineering Czech Technical University Prague Prague Czech Republic

Department of Neurology and Centre of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Neurology Philipps University Marburg Marburg Germany

Institute of Nuclear Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czechia

000      

00000naa a2200000 a 4500

001      

bmc22019315

003      

CZ-PrNML

005      

20220804135545.0

007      

ta

008      

220720s2022 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1002/mds.28873 $2 doi

035    __

$a (PubMed)34837250

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Rusz, Jan $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000210363054 $7 xx0093732

245    10

$a Dysprosody in Isolated REM Sleep Behavior Disorder with Impaired Olfaction but Intact Nigrostriatal Pathway / $c J. Rusz, A. Janzen, T. Tykalová, M. Novotný, D. Zogala, L. Timmermann, E. Růžička, K. Šonka, P. Dušek, W. Oertel

520    9_

$a BACKGROUND: Impairments of olfactory and speech function are likely early prodromal symptoms of α-synucleinopathy. OBJECTIVE: The aim of this study is to assess whether dysprosody is present in isolated rapid eye movement sleep behavior disorder (iRBD) with hyposmia/anosmia and a normal nigrostriatal system. METHODS: Pitch variability during speech was investigated in 17 iRBD subjects with normal olfactory function (iRBD-NOF), 30 iRBD subjects with abnormal olfactory function (iRBD-AOF), and 50 healthy controls. iRBD subjects were evaluated using the University of Pennsylvania Smell Identification Test and [123I]-2ß-carbomethoxy-3ß-(4-iodophenyl)-N-(3-fluoropropyl)-nortropane dopamine transporter single-photon emission computed tomography (DAT-SPECT). All iRBD subjects completed the 24-month follow-up with DAT-SPECT, speech, and olfactory testing. RESULTS: At baseline, only iRBD-AOF showed monopitch when compared to iRBD-NOF (P = 0.04) and controls (P = 0.03), with no difference between iRBD-NOF and controls (P = 1). At follow-up, dysprosody progressed only in iRBD-AOF with abnormal DAT-SPECT (P = 0.03). CONCLUSION: Prosody is impaired in hyposmic but not in normosmic iRBD subjects before the nigrostriatal dopaminergic transmission is affected (Braak stage 2). © 2021 International Parkinson and Movement Disorder Society.

650    _2

$a dopamin $x metabolismus $7 D004298

650    _2

$a lidé $7 D006801

650    12

$a poruchy čichu $x diagnostické zobrazování $x etiologie $7 D000857

650    12

$a porucha chování v REM spánku $7 D020187

650    12

$a synukleinopatie $7 D000080874

650    _2

$a jednofotonová emisní výpočetní tomografie $x metody $7 D015899

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Janzen, Annette $u Department of Neurology, Philipps University Marburg, Marburg, Germany $1 https://orcid.org/0000000189075831

700    1_

$a Tykalová, Tereza $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic

700    1_

$a Novotný, Michal $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic

700    1_

$a Zogala, David $u Institute of Nuclear Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia

700    1_

$a Timmermann, Lars $u Department of Neurology, Philipps University Marburg, Marburg, Germany

700    1_

$a Růžička, Evžen $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000248939661 $7 jo20000074065

700    1_

$a Šonka, Karel $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic

700    1_

$a Dušek, Petr $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000348779642 $7 jo2013795390

700    1_

$a Oertel, Wolfgang $u Department of Neurology, Philipps University Marburg, Marburg, Germany

773    0_

$w MED00003420 $t Movement disorders : official journal of the Movement Disorder Society $x 1531-8257 $g Roč. 37, č. 3 (2022), s. 619-623

856    41

$u https://pubmed.ncbi.nlm.nih.gov/34837250 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20220720 $b ABA008

991    __

$a 20220804135538 $b ABA008

999    __

$a ok $b bmc $g 1822776 $s 1170558

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2022 $b 37 $c 3 $d 619-623 $e 20211126 $i 1531-8257 $m Movement disorders $n Mov Disord $x MED00003420

LZP    __

$a Pubmed-20220720